Comparative study of the efficacy of breast cancer neoadjuvant chemotherapy (NAC) in patients (pts) with BRCA1/2 mutation vs sporadic cancer cases versus pts with a family history but no BRCA1/2 mutation

Authors
Publication date
1 January 2013
Publisher
'American Society of Clinical Oncology (ASCO)'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    DIAL UCLouvain

    redirect
    oaioai:dial.uclouvain.be:boreal:1...
    Last time updated on 23/09/2018